Pictet Asset Management (UK)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $209K | Sell |
3,684
-316
| -8% | -$17.9K | ﹤0.01% | 1607 |
|
|
2021
Q1 | $299K | Sell |
4,000
-400
| -9% | -$29.9K | ﹤0.01% | 1434 |
|
|
2020
Q4 | $381K | Hold |
4,400
| – | – | ﹤0.01% | 1262 |
|
|
2020
Q3 | $269K | Buy |
+4,400
| New | +$269K | ﹤0.01% | 1275 |
|
|
2020
Q2 | – | Sell |
-77,056
| Closed | -$2.21M | – | 1194 |
|
|
2020
Q1 | $2.21M | Sell |
77,056
-262,642
| -77% | -$7.54M | ﹤0.01% | 831 |
|
|
2019
Q4 | $24.5M | Buy |
339,698
+101,763
| +43% | +$7.35M | 0.04% | 383 |
|
|
2019
Q3 | $33.4M | Sell |
237,935
-172,737
| -42% | -$24.2M | 0.07% | 298 |
|
|
2019
Q2 | $75.2M | Sell |
410,672
-33,900
| -8% | -$6.21M | 0.16% | 167 |
|
|
2019
Q1 | $70.7M | Sell |
444,572
-9,472
| -2% | -$1.51M | 0.16% | 185 |
|
|
2018
Q4 | $43.5K | Buy |
454,044
+62,496
| +16% | +$5.99K | 0.11% | 232 |
|
|
2018
Q3 | $55.3M | Buy |
391,548
+10,257
| +3% | +$1.45M | 0.12% | 230 |
|
|
2018
Q2 | $59.7M | Sell |
381,291
-8,188
| -2% | -$1.28M | 0.14% | 201 |
|
|
2018
Q1 | $62.7M | Sell |
389,479
-80,131
| -17% | -$12.9M | 0.15% | 191 |
|
|
2017
Q4 | $77.4M | Buy |
469,610
+90,565
| +24% | +$14.9M | 0.2% | 156 |
|
|
2017
Q3 | $23.6M | Sell |
379,045
-100,968
| -21% | -$6.29M | 0.07% | 334 |
|
|
2017
Q2 | $31.7M | Buy |
480,013
+52,124
| +12% | +$3.45M | 0.1% | 264 |
|
|
2017
Q1 | $30.4M | Buy |
427,889
+134,347
| +46% | +$9.55M | 0.1% | 263 |
|
|
2016
Q4 | $15M | Sell |
293,542
-49,887
| -15% | -$2.55M | 0.06% | 371 |
|
|
2016
Q3 | $15.8M | Sell |
343,429
-93,109
| -21% | -$4.29M | 0.06% | 357 |
|
|
2016
Q2 | $14.4M | Buy |
436,538
+395,238
| +957% | +$13M | 0.06% | 356 |
|
|
2016
Q1 | $1.21M | Buy |
+41,300
| New | +$1.21M | 0.01% | 743 |
|